Patents by Inventor Matthew Patrick Mullarney

Matthew Patrick Mullarney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID DOSAGE FORMS OF PALBOCICLIB
    Publication number: 20210315900
    Abstract: The present invention relates to solid dosage forms of palbociclib comprising a water-soluble acid. The dosage forms described herein have desirable pharmacokinetic characteristics.
    Type: Application
    Filed: June 17, 2021
    Publication date: October 14, 2021
    Applicant: PFIZER INC.
    Inventors: Fady Makram Louiz Ibrahim, Matthew Patrick Mullarney, Ravi M. Shanker, Barbara Rodriguez Spong, Jian Wang
  • Solid dosage forms of palbociclib
    Patent number: 11065250
    Abstract: The present invention relates to solid dosage forms of palbociclib comprising a water-soluble acid. The dosage forms described herein have desirable pharmacokinetic characteristics.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: July 20, 2021
    Assignee: Pfizer Inc.
    Inventors: Fady Makram Louiz Ibrahim, Matthew Patrick Mullarney, Ravi M. Shanker, Barbara Rodriguez Spong, Jian Wang
  • SOLID DOSAGE FORMS OF PALBOCICLIB
    Publication number: 20180207100
    Abstract: The present invention relates to solid dosage forms of palbociclib comprising a water-soluble acid. The dosage forms described herein have desirable pharmacokinetic characteristics.
    Type: Application
    Filed: May 24, 2016
    Publication date: July 26, 2018
    Applicant: PFIZER INC.
    Inventors: Fady Makram Louiz Ibrahim, Matthew Patrick Mullarney, Ravi M. Shanker, Barbara Rodriguez Spong, Jian Wang